2279.HK
Legend is a health company

Hair transplant company Yonghe Medical Group Co. Ltd. (2279.HK) on Tuesday said it returned to the black in the first half of 2025, adding it expects to report a net profit of 25 million yuan ($3.48 million) for the period. It recorded a net loss of 139 million yuan in the year-ago period.

The company credited the return to profitability on improvements to its clinic network and centralization of resources at its core operations. It said it also continues to enhance its Hefan proprietary healthcare chain management IT system. The company said it has significantly improved its customer conversion efficiency and return on investment by fine-tuning its management model and improving its marketing spending.

Shares of Yonghe Medical opened flat at HK$3.54 on Tuesday but then fell over 5% in early trade. The stock has more than tripled since the beginning of this year.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, clickhere

Recent Articles

Illustration of Chinese government pumping confidence into stock market

China’s state-driven stocks, and its corporate wars abroad

China's stock market rally is fast approaching its one-year mark, with the benchmark Hang Seng and Shanghai composite indexes both up around 40%. How much longer can it last, especially given the weak state of China's economy? And internet giants Meituan and DiDi have sued each other in Brazil, where they are competing in the takeout dining market. How is this case likely to end up?